Bio-Rad Laboratories (BIO) News Today $234.89 -10.63 (-4.33%) As of 04/3/2025 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by CIBC Private Wealth Group LLCCIBC Private Wealth Group LLC lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 2.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 42,106 shares of the medical research company's stoApril 2 at 4:58 AM | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Reaches New 1-Year Low - Here's WhyBio-Rad Laboratories (NYSE:BIO) Reaches New 12-Month Low - Here's What HappenedApril 2 at 4:11 AM | marketbeat.comMitsubishi UFJ Trust & Banking Corp Has $2.68 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Mitsubishi UFJ Trust & Banking Corp decreased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 14.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,161 shares of the medical research company'sApril 2 at 3:58 AM | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Vanguard Group Inc.Vanguard Group Inc. grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 0.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,919,808 shares of the medical research company's stock after acquiriApril 1 at 3:47 AM | marketbeat.comMawer Investment Management Ltd. Grows Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Mawer Investment Management Ltd. lifted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 17.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 256,927 shares of the medical research company's stock after purchasiMarch 31, 2025 | marketbeat.comKLP Kapitalforvaltning AS Purchases New Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)KLP Kapitalforvaltning AS purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 7,100 shares of the medical research company's stock, valued at approxiMarch 29, 2025 | marketbeat.comBio-Rad Laboratories (BIO) Receives a Hold from JefferiesMarch 29, 2025 | markets.businessinsider.comBio-Rad Laboratories (NYSE:BIO) Hits New 12-Month Low - Here's WhyBio-Rad Laboratories (NYSE:BIO) Hits New 1-Year Low - Should You Sell?March 27, 2025 | marketbeat.comBIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ETMarch 27, 2025 | globenewswire.com15,581 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 15,581 shares of the medical researchMarch 26, 2025 | marketbeat.comFox Run Management L.L.C. Buys New Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO)Fox Run Management L.L.C. bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,122 shares of the medical research company's stMarch 24, 2025 | marketbeat.comSei Investments Co. Acquires 18,873 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Sei Investments Co. boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 7.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 271,387 shares of the medical research company's stock afMarch 24, 2025 | marketbeat.comNatixis Advisors LLC Buys 4,390 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Natixis Advisors LLC grew its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 10.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,713 shares of the medical research company's stock afMarch 19, 2025 | marketbeat.comSwiss National Bank Cuts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Swiss National Bank lessened its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 7.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,700 shares of the medical research cMarch 19, 2025 | marketbeat.comAvantax Advisory Services Inc. Sells 1,365 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Avantax Advisory Services Inc. trimmed its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 23.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,336 shares of the medical research company's stock afterMarch 19, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Recommendation of "Moderate Buy" from BrokeragesBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five ratings firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and three have given a buy recMarch 19, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Sees Large Increase in Short InterestBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) saw a large growth in short interest in February. As of February 28th, there was short interest totalling 862,700 shares, a growth of 41.4% from the February 13th total of 610,000 shares. Based on an average trading volume of 230,900 shares, the short-interest ratio is currently 3.7 days. Approximately 4.5% of the company's stock are sold short.March 17, 2025 | marketbeat.comLbp Am Sa Purchases New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Lbp Am Sa purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 4,397 shares of the medical research company's stock, valued at approximately $1,444,000. Several otherMarch 17, 2025 | marketbeat.comTredje AP fonden Has $553,000 Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Tredje AP fonden trimmed its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 50.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,684 shares of the medical research compMarch 16, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Has $3.48 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 67.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,588 shares of the medical research company's stMarch 16, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Holdings Reduced by AmundiAmundi lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 45.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,042 shares of the medical research company's stock after selling 16,596 shares dMarch 16, 2025 | marketbeat.comProficio Capital Partners LLC Buys Shares of 29,894 Bio-Rad Laboratories, Inc. (NYSE:BIO)Proficio Capital Partners LLC bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 29,894 shares of the mMarch 16, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Thompson Siegel & Walmsley LLCThompson Siegel & Walmsley LLC decreased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 15.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 258,153 shares of the medicalMarch 14, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Boosts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Charles Schwab Investment Management Inc. grew its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 191,867 shares of the medical research company's stock after buyingMarch 13, 2025 | marketbeat.comWealthfront Advisers LLC Purchases Shares of 1,043,153 Bio-Rad Laboratories, Inc. (NYSE:BIO)Wealthfront Advisers LLC purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,043,153 shares of the medical research company's stoMarch 12, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Reaches New 12-Month Low - What's Next?Bio-Rad Laboratories (NYSE:BIO) Sets New 12-Month Low - Time to Sell?March 11, 2025 | marketbeat.comAssetmark Inc. Buys 7,605 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Assetmark Inc. raised its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 2,493.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,910 shares of the medical reseMarch 10, 2025 | marketbeat.comZacks Research Has Negative Outlook of BIO Q1 EarningsBio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Stock analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for Bio-Rad Laboratories in a research note issued to investors on Thursday, March 6th. Zacks Research analyst R. Department now expects that the medical reseaMarch 10, 2025 | marketbeat.comWhat is Zacks Research's Estimate for BIO Q3 Earnings?Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Stock analysts at Zacks Research decreased their Q3 2025 earnings estimates for Bio-Rad Laboratories in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst R. Department now forecasts that the medicMarch 8, 2025 | marketbeat.comCandriam S.C.A. Buys 2,220 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Candriam S.C.A. raised its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 7.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 33,747 shares of the medical research company's stock after acquiring an additional 2,March 8, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) is a favorite amongst institutional investors who own 60%March 7, 2025 | finance.yahoo.comBio-Rad Laboratories Q4 Earnings TranscriptMarch 6, 2025 | marketbeat.comExencial Wealth Advisors LLC Invests $4.12 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Exencial Wealth Advisors LLC acquired a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 12,533 shares of the medical research company's stock, valued at approMarch 5, 2025 | marketbeat.comMarathon Asset Management Ltd Trims Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Marathon Asset Management Ltd cut its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 6.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 67,127 shares of the medical research company's stock afMarch 3, 2025 | marketbeat.comFisher Asset Management LLC Grows Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Fisher Asset Management LLC lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 15.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 106,871 shares of the medical researchMarch 3, 2025 | marketbeat.comProficio Capital Partners LLC Invests $9.82 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Proficio Capital Partners LLC bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 29,894 shares of the medical researchMarch 3, 2025 | marketbeat.comBank of New York Mellon Corp Trims Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Bank of New York Mellon Corp reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 0.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 267,306 shares of the medical research company's stock after sellingMarch 3, 2025 | marketbeat.comAsahi Life Asset Management CO. LTD. Invests $350,000 in Bio-Rad Laboratories, Inc. (NYSE:BIO)Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,065 shares ofMarch 2, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Sets New 12-Month Low - Here's WhyBio-Rad Laboratories (NYSE:BIO) Reaches New 12-Month Low - Here's WhyMarch 1, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Stock Holdings Lessened by Hosking Partners LLPHosking Partners LLP reduced its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 11.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 54,992 shares of the medical research company's stock after selling 7,118 shaMarch 1, 2025 | marketbeat.comNew York State Common Retirement Fund Sells 1,000 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)New York State Common Retirement Fund lowered its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 8.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,075 shares of the medical research coMarch 1, 2025 | marketbeat.comFjarde AP Fonden Fourth Swedish National Pension Fund Has $1.14 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 52.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,480 shares of the medical research companyFebruary 27, 2025 | marketbeat.comUniversity spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosisFebruary 26, 2025 | msn.comVeritas Asset Management LLP Sells 109,652 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Veritas Asset Management LLP decreased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 976,827 shares of the mediFebruary 25, 2025 | marketbeat.comBlackhawk Capital Partners LLC. Increases Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Blackhawk Capital Partners LLC. increased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 190.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,176 shares ofFebruary 25, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) have received an average rating of "Moderate Buy" from the five brokerages that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and three have issued a buy recomFebruary 22, 2025 | marketbeat.comBio-Rad Laboratories Updates on Sartorius InvestmentFebruary 21, 2025 | tipranks.comPrincipal Securities Inc. Raises Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Principal Securities Inc. boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 1,501.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 2,994 shares of the medical research company's stock after buying an additionaFebruary 20, 2025 | marketbeat.comEmpowered Funds LLC Takes $443,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Empowered Funds LLC purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,348 shares of the medical research company's stoFebruary 20, 2025 | marketbeat.comBio-Rad sued by Caltech over DNA analysis technologyFebruary 19, 2025 | reuters.com Remove Ads Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address BIO Media Mentions By Week BIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼1.070.61▲Average Medical News Sentiment BIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼76▲BIO Articles Average Week Remove Ads Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Charles River Laboratories International News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow you could profit from Elon’s latest AI breakthroughEvery single one of Elon's projects minted an entire new class of millionaires. And xAI could be next in li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
